Literature DB >> 25650809

Inguinal lymph node and anorectal mucosal biopsies for human immunodeficiency virus research protocols in an emerging nation: patient outcomes and lessons learned.

Meghan K Rothenberger1, C Kityo Mutuluuza, F Ssali, Jake Jasurda, Thomas Schmidt, Timothy W Schacker, Greg J Beilman, Jeffrey G Chipman.   

Abstract

BACKGROUND: Lymph nodes and gut-associated lymphatic tissue are important reservoirs of the human immunodeficiency virus (HIV). Little is known about these reservoirs in different geographic populations. We report the surgical outcomes of excisional lymph node and anorectal mucosal biopsies performed internationally and describe the lessons learned.
METHODS: Patients were recruited through the Joint Clinical Research Center (JCRC) in Kampala, Uganda, where procedures were performed. Studies were approved by the Institutional Review Boards of the JCRC and the University of Minnesota. Instruments and supplies were shipped to Uganda and prepared onsite. Drugs and skin preparations were purchased locally. Lymph nodes were removed through 1-3 cm incisions with ligatures on lymphovascular pedicles. Incisions were closed with subcuticular sutures and epidermal tape. Two to four pieces of anorectal mucosa were obtained through anoscopes using biopsy forceps.
RESULTS: One hundred thirty-eight lymph node biopsies and 98 anorectal mucosal biopsies were performed on 71 patients. Forty-one patients were HIV-positive. Many patients had multiple procedures. Two minor complications resulted: One hematoma and one lymphocele. Despite the cost of travel and lodging, cost per biopsy was lower in Uganda compared with the United States.
CONCLUSION: Invasive clinical research can be performed with minimal morbidity in emerging nations with outcomes similar to those found in the United States, but with lower cost.

Entities:  

Mesh:

Year:  2015        PMID: 25650809      PMCID: PMC4363795          DOI: 10.1089/sur.2013.179

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  11 in total

1.  Re-emergence of HIV after stopping therapy.

Authors:  T W Chun; R T Davey; D Engel; H C Lane; A S Fauci
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

2.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 3.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

Authors:  A T Haase
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 4.  The role of lymphoid organs in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; C Graziosi; A S Fauci
Journal:  AIDS       Date:  1993       Impact factor: 4.177

5.  Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.

Authors:  Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Torsten B Neilands; Colleen F Kelley; Peter W Hunt; Rebecca Hoh; Jeffrey M Linnen; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

6.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.

Authors:  René Raaijmakers; Wim J Kirkels; Monique J Roobol; Mark F Wildhagen; Fritz H Schrder
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

7.  Inguinal lymph node biopsy in patients infected with the human immunodeficiency virus is safe.

Authors:  David E Skarda; Jodie H Taylor; Jeffrey G Chipman; Matthew Larson; Jason V Baker; Timothy W Schacker; Gregory J Beilman
Journal:  Surg Infect (Larchmt)       Date:  2007-04       Impact factor: 2.150

8.  Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

Authors:  Tae-Wook Chun; J Shawn Justement; Danielle Murray; Claire W Hallahan; Janine Maenza; Ann C Collier; Prameet M Sheth; Rupert Kaul; Mario Ostrowski; Susan Moir; Colin Kovacs; Anthony S Fauci
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

9.  Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Authors:  Sarah Palmer; Frank Maldarelli; Ann Wiegand; Barry Bernstein; George J Hanna; Scott C Brun; Dale J Kempf; John W Mellors; John M Coffin; Martin S King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

10.  Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.

Authors:  Viktor von Wyl; Sara Gianella; Marek Fischer; Barbara Niederoest; Herbert Kuster; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Andri Rauch; Bernard Hirschel; Pietro Vernazza; Rainer Weber; Beda Joos; Huldrych F Günthard
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

View more
  3 in total

1.  Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Authors:  Marta E Bull; Jennifer L McKernan; Sheila Styrchak; Kelli Kraft; Jane Hitti; Susan E Cohn; Kenneth Tapia; Wenjie Deng; Sarah Holte; James I Mullins; Robert W Coombs; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-30       Impact factor: 2.205

2.  Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand.

Authors:  Michelle Chintanaphol; Carlo Sacdalan; Suthat Chottanapund; Suteeraporn Pinyakorn; Supranee Buranapraditkun; Trevor A Crowell; Eugene Kroon; Sopark Manasnayakorn; Jeffrey G Chipman; Timothy W Schacker; Nelson Michael; Nittaya Phanuphak; Serena S Spudich; Donn J Colby; Jintanat Ananworanich
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

3.  Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis.

Authors:  Cassandra Moats; Kimberly Cook; Kimberly Armantrout; Hugh Crank; Samantha Uttke; Kelly Maher; Rachele M Bochart; George Lawrence; Michael K Axthelm; Jeremy V Smedley
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.